Last Updated: July 13, 2026

Suppliers and packagers for urex


✉ Email this page to a colleague

« Back to Dashboard


urex

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Quagen UREX methenamine hippurate TABLET;ORAL 016151 NDA Alvogen Inc. 47781-577-01 100 TABLET in 1 BOTTLE (47781-577-01) 2010-05-03
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for urex

Last updated: June 10, 2026

Urex Drug Suppliers: Who Manufactures and Supplies Urex (Active Ingredient, Brands, and Distribution)

Urex is a brand name that can map to more than one pharmaceutical product depending on country and formulation (for example, “urea” topical products versus other brand uses). No regulator-linked product identity, strength, dosage form, or country is provided, so a complete and accurate supplier map cannot be produced.

What suppliers manufacture Urex drug products (by active ingredient and dosage form)?

Answer: Not determinable from the provided input.

Which “Urex” brands exist and who supplies them?

Answer: Not determinable from the provided input.

How to interpret “Urex” as a supplier search term

“Urex” is a short brand string that may refer to different products across jurisdictions. Supplier identification requires at least one of the following: active ingredient, strength, dosage form (cream, tablet, suspension, etc.), or the market/country.

Which companies are authorized suppliers of Urex through distributors and wholesalers?

Answer: Not determinable from the provided input.

Distribution chains: marketing authorization holder vs. manufacturing site

Answer: Not determinable from the provided input.

What is the FDA or Orange Book status of Urex (and does that identify suppliers)?

Answer: Not determinable from the provided input.

Which pathway would Urex use in the US (NDA, ANDA, 505(b)(2))?

Answer: Not determinable from the provided input.

How many manufacturing sites supply Urex (CDMO vs. in-house)

Answer: Not determinable from the provided input.

What GMP manufacturing data would list Urex suppliers?

Answer: Not determinable from the provided input.

What generic or parallel-supply risks exist for Urex products?

Answer: Not determinable from the provided input.

How do different formulations of “Urex” change supplier risk?

Answer: Not determinable from the provided input.

Which regional suppliers dominate Urex markets (country-by-country)?

Answer: Not determinable from the provided input.

What to check for each country

Answer: Not determinable from the provided input.

How does Urex supplier coverage compare with similar products (e.g., urea topical lines)?

Answer: Not determinable from the provided input.

Key Takeaways

  • “Urex” is insufficient to identify a single pharmaceutical product and its suppliers.
  • Supplier mapping requires product identity by active ingredient, strength, dosage form, and market.
  • No authoritative supplier list can be generated from the provided input.

FAQs

  1. Is Urex the same drug everywhere it is sold?
  2. Does “Urex” refer to urea topical products in all markets?
  3. How can I identify the manufacturing company behind Urex without a package insert?
  4. Where would supplier data be listed for Urex in the US?
  5. Do Urex generics use the same manufacturing sites as the reference product?

References

No sources were cited because the product identity needed to verify suppliers was not provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.